<DOC>
	<DOCNO>NCT02110446</DOCNO>
	<brief_summary>To evaluate efficacy Chinese herbal medicine ( SS-1 ) Sjögren 's syndrome ( SJS ) patient .</brief_summary>
	<brief_title>Evaluation Efficacy Mechanism Chinese Herbal Formula SS-1 Sjögren 's Syndrome</brief_title>
	<detailed_description>Investigators take randomize , double-blinded , placebo-controlled , cross-over design clinical trial evaluate effect Chinese herbal medicine ( SS-1 ) regulation oxidative-related cytokine antioxidant capacity Sjögren 's syndrome ( SJS ) patient . Through oxidative stress reduction , quality life clinical manifestation improve . Investigators also use SJS cell model elucidate antioxidant mechanism SS-1 . The SJS patient clinical trial screen referred out-patient department ( OPD ) Rheumatology Department Chang Gung Memorial Hospital . The patient divide two group ( A B ) random keep routine treatment rheumatology OPD . Group A patient receive 12 week SS-1 treatment first stop SS-1 4 week enter wash-out phase , receive 12 week placebo treatment wash-out phase . Group B patient receive 12 week placebo first stop placebo treatment 4 week enter wash-out phase , receive 12 week SS-1 treatment wash-out phase . SS-1 compose powder Gan-Lu-Yin , Sang-Ju-Yin Xuefu-Zhuyu-Decoction ratio 2:1:1 placebo compose corn starch , pigment 1/100 SS-1 . Patients group take 6 gram experiment medicine three time per day . Investigators plan evaluate associate parameter time treatment ( V1 ) , treatment 12 week ( V2 ) , end wash-out phase ( V3 ) crossover treatment complete ( V4 ) . Investigators use EULAR Sjogren 's syndrome patient report index , ocular surface disease index SJS symptom questionnaire clinical evaluation , use SF-36 quality life . And investigator use schirmer 's test , salivary scintigraphy , oxidative stress marker relate cytokine objective observation . Expected Results : 1 . SS-1 may improve clinical manifestation quality life patient Sjögren 's syndrome 2 . To evaluate effect Chinese medicine tongue diagnosis treatment . 3 . SS-1 may reduce oxidative stress ( 8-OHdG mtDNA 4977 bp deletion ) elevate antioxidant capacity ( TAC , GSH , mtDNA copy number , SOD , GPX , CAT ) . 4 . SS-1 may regulatory effect cytokine secretion immune function . 5 . SS-1 may capacity reduce oxidative stress , elevate antioxidant capacity regulate immune response model submaxillary salivary gland cell line induction IFN-γand IFN-α . 6 . Identification single herb SS-1 mixture regulate oxidative stress cytokine model submaxillary salivary gland cell line , set Chinese herb screen platform Sjögren 's syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<criteria>Primary Secondary Sjögren 's syndrome patient Age 20 75 year old , male female patient Fit criterion 2002 year AmericanEuropean classification If subject take Cyclosporine , Cevimeline , Pilocarpine , Rituximab biological agent enter study , subject need stop drug one month If subject take GanLuYin , Sang JuYin XuefuZhuyuDecoction enter study , subject need stop drug one month Secondary Sjögren 's syndrome patient : Stable treatment : Steroid ( ≦10mg/d ) fix hydroxychloroquine dose 3 month enrol No abnormal change immunology , liver , kidney , blood function No major life threaten condition Alcohol abuse , DM ( Glucose PC &gt; 200mg/dL ) major life threaten condition Pregnancy breast feed Abnormal liver kidney function Forbid steroid pulse therapy 3 month enrol study , forbid Chinese herbal medicine except SS1</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Sjögren 's syndrome</keyword>
	<keyword>SS-1</keyword>
	<keyword>Gan-Lu-Yin</keyword>
	<keyword>Sang-Ju-Yin</keyword>
	<keyword>Xuefu-Zhuyu-Decoction</keyword>
</DOC>